COVID-19 pill molnupiravir, maaaring ireseta basta’t may compassionate special permit – FDA

Robie de Guzman   •   November 23, 2021   •   396

MANILA, Philippines – Maaari nang mag-reseta ng COVID-19 pill na molnupiravir ang mga ospital at doktor na nabigyan ng compassionate special permit.

Ginawa ni Food and Drug Administration (FDA) director general Eric Domingo ang pahayag matapos sabihin ni Vice President Leni Robredo na may supply na sila ng molnupiravir na maaaring ireseta sa mga kokonsulta sa Bayanihan E-Konsulta program ng kanyang tanggapan.

Ang gamot na molnupiravir ay isang oral pill para sa treatment ng mild to moderate cases ng COVID-19.

Ani Domingo, ang mga doktor at ospital na nabigyan ng compassionate special permit ang may obligasyong mag-monitor sa mga pasyenteng bibigyan ng oral antiviral pill.

Sa isang Facebook post noong Lunes, sinabi ni Robredo na may kasunduan na ang Office of the Vice President (OVP) sa Qualimed Health Network na siyang magus-supply at magre-reseta ng molnupiravir sa mga pasyenteng dudulog sa kanilang teleconsultation program.

“In the agreement, the OVP will issue a guarantee letter under our special medical assistance program to any qualified patient referred by our volunteer doctors at Bayanihan E-Konsulta. QualiMed facilties will then further assess and prescribe the medicine to the patient,” ani Robredo.

Inihayag rin ni Robredo na ang unang shipment ng nasabing gamot ay dumating sa bansa noong Nobyembre 17.

Sa isang Twitter post naman ni Manila Mayor Francisco “Isko Moreno” Domagoso, sinabi niyang may 40,000 capsules ng molnupirarvir ang nasa anim na district hospitals at COVID-19 field hospitals ng Maynila.

Sa datos ng mga ekspertong nagsagawa ng clinical trials sa iba’t ibang bansa, kabilang ang dalawang ospital sa Pilipinas, sinasabing mabisa ang molnunpiravir para maiwasang maopsital at masawi ang isang pasyenteng may COVID-19.

Kumpara sa ibang COVID-19 investigational drugs, ang molnupiravir ay idinesenyo para sa early treatment ng mga pasyente.

Ngunit paalala ng FDA, hindi pa maaaring ibenta sa merkado ang naturang gamot dahil wala pa itong certificate of product registration.

Una nang sinabi ng ahensiya na hindi maaaring ipagbili ang mga gamot o bakuna na wala pang emergency use authorization at hindi pa rehistrado sa bansa. (Mula sa ulat ni Correspondent Aiko Miguel)

Aplikasyon para sa 2 brand ng COVID-19 self-test kits, pinoproseso na – FDA

Robie de Guzman   •   January 11, 2022

MANILA, Philippines – Sinisimulan na ng Food and Drug Administration (FDA) ang pagproseso sa aplikasyon ng dalawang brand ng COVID-19 self-test kits.

Ayon kay FDA director general Oscar Guiterrez, sinusuri na ng ahensiya ang mga aplikasyon para sa paglalabas ng special certification

“Dalawa po ang ini-evaluate ng FDA sa ngayon. Na-endorse na po ito kahapon sa RITM para sa technical validation. Once matapos po ng RITM, pwede na po mabigyan ng FDA ng special certification,” ani Gutierrez.

Habang wala pang aprubadong COVID-19 home test kits sa bansa, nagpaalala ang Department of Trade and Industry (DTI) sa publiko na mag-ingat sa mga ibinibentang COVID-19 home test kits online.

Ayon kay DTI Assistant Secretary Ann Claire Cabochan, hindi dapat tangkilikin ang mga ‘di rehistradong self-administered tesing kits dahil hindi tiyak kung ligtas itong gamitin o kung dumaan sa pagsusuri ng mga eksperto.

“Doon sa mga self-test kits na alam ko din na naging very in demand as of this time, of course, that has not been given the proper certification from the Food and Drug Administration to be sold here in the Philippines kaya hindi siya talaga dapat ibinebenta,” ani Cabochan.

Babala ng opisyal, maaaring maharap sa reklamo ang sinomang nagbebenta ng hindi rehistradong self-test kits sa bansa.

pwede nating habulin yung mga nagbebenta n’yan online for as long as this is not certified as legitimate to be sold in the Philippines,” ani Cabochan. (mula sa ulat ni Correspondent Joan Nano)

PH FDA says application for certification of self-administered COVID test kits now open

Robie de Guzman   •   January 7, 2022

MANILA, Philippines – The Food and Drug Administration (FDA) announced it has opened the applications for the certification of home test kits for COVID-19 amid the demand for testing due to the growing infection rate.

“I am calling po all the manufacturers and even the importers of self-administered COVID-19 test kits that — to register their product in a form of special certification,” Dr. Oscar Gutierrez Jr., FDA OIC director general, said during President Rodrigo Duterte’s Talk to the People on Thursday.

Gutierrez said they have already met with the Department of Health (DOH) for the issuance of the guidelines on the use of these self-administered kits and how people who use them can report the results.

 “We already met with the DOH and they will be coming out with an algorithm actually a guideline or policy on the use of these home test kits considering that these products need to be administered by the patient or the household themselves,” he said.

“Kailangan po natin ng guidelines on the use, reporting system, even disposal of the waste, interpretation of the test results, and what actions should the individual take when he finds out that he is positive,” he added.

Gutierrez said self-administered test kits will get samples from individuals orally or through the mouth, and nasally or through the nose.

All the antigen test kits currently approved by the FDA are only administered by laboratories and healthcare professionals.

The DOH earlier reiterated the proper use of antigen test kits at the right time for more accurate test results. The agency said antigen test is better used to check symptomatic persons for COVID-19 infection.

Domingo resigns as FDA chief

Maris Federez   •   January 3, 2022

 

MANILA, Philippines — Dr. Eric Domingo on Monday confirmed his resignation as director-general of the Food and Drug Administration (FDA) effective January 3, 2022.

In a text message to reporters, Domingo said he is resigning as “he already did his part during the pandemic”.

“The FDA is now stronger, more efficient and systems are in place. It’s time for me to move on to other things,” he added.

The Department of Health (DOH), in a statement, also confirmed Domingo’s resignation, adding that FDA deputy director-general Dr. Oscar Guiterrez has been appointed as the department’s officer-in-charge, replacing Domingo.

“Yes. We confirm the resignation of FDA Director-General Eric Domingo. Dr. Oscar Gutierrez, Deputy Director-General, FDA, was assigned as OIC,” the statement read.

Domingo was first appointed as OIC of the FDA in May 2019.

President Rodrigo Duterte appointed him as director-general in February 2020. —/mbmf

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.